Rockley Photonics , a global leader in photonics-based health monitoring and communications solutions, formed a strategic relationship to incorporate Rockley’s non-invasive biomarker sensing platform into potential clinical and healthcare research studies. Rockley will be working with the Icahn School of Medicine at Mount Sinai in New York, NY, part of the Mount Sinai Health System, for potential collaboration in future research studies.
The initiative aims to incorporate the next generation of non-invasive biomarker sensing in a series of studies to evaluate the use of wristbands and other wearables for a variety of potential applications, including remote monitoring and diagnosis. Rockley aims to create new opportunities for its photonics-based sensing platform in healthcare and medical applications and help expand the future use of real-time, non-invasive biomarker sensing for people around the globe.
“At Mount Sinai, we pride ourselves on our full-spectrum healthcare activities and relentless pursuit of leveraging the latest cutting-edge technologies in our research,” said Zahi A. Fayad, director of the BioMedical Engineering and Imaging Institute, at the Icahn School of Medicine at Mount Sinai. “We look forward to designing studies that evaluate the application of mobile, non-invasive sensing capabilities and examine the ability to identify biomarker correlations. The results have the potential for real and substantial impact in mobile health and clinical care.”
“We are honored and delighted to incorporate our unique biomarker sensing technology in what could be many exciting and truly eye-opening research studies,” said Dr. Andrew Rickman, chief executive officer and founder of Rockley Photonics. “The learnings gained from these studies have the potential to accelerate the development of new algorithms and applications in remote healthcare, from real-time biomarker measurement to early disease state identification. By enabling these new capabilities on a small wearable device, we expect to bring easier access to key health insights to larger and more diverse populations.”
Rockley’s sensing platform enables clinical and healthcare research practitioners to integrate more comprehensive non-invasive biomarker measurements in their remote monitoring studies. Rockley’s patented silicon photonics-based laser technology significantly expands the range of biomarkers that can be detected and measured by current LED-based sensors. This expanded range includes key biomarkers like core body temperature, blood pressure, body hydration, alcohol, lactate, and glucose trends, among others. These new measurement capabilities have the potential to transform digital healthcare by providing real-time insights into a variety of health conditions and by enabling early detection of multiple disease states.
About Rockley Photonics
A global leader in photonics-based health monitoring and communications solutions, Rockley Photonics is developing a comprehensive range of photonic integrated circuits and associated modules, sensors, and full-stack solutions. From next-generation sensing platforms specifically designed for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the foundation for a new generation of applications across multiple industries. Rockley believes that photonics will eventually become as pervasive as micro-electronics, and it has developed a platform with the power and flexibility needed to address both mass markets and a wide variety of vertical applications.
Formed in 2013, Rockley is uniquely positioned to support hyper-scale manufacturing and address a multitude of high-volume markets. Rockley has partnered with numerous tier-1 customers across a diverse range of industries to deliver the complex optical systems required to bring transformational products to market.